Bionano Genomics held its 2026 Annual Meeting on May 14, 2026, with stockholders electing directors and approving executive compensation and auditor ratification.
Key takeaways
Stockholders elected Albert Luderer and Kristiina Vuori as Class II directors with majority support.
Advisory vote on executive compensation passed with 697,999 for, 216,553 against.
Ratification of BDO USA as auditor for FY2026 received overwhelming approval (3,770,715 for).
Approximately 38.1% of outstanding shares were represented at the meeting.